FIELD: medicine.
SUBSTANCE: group of inventions refers to medicine, namely to infectious diseases, and aims at inhibiting one or more microbial infections in a subject. Antimicrobial composition contains an effective amount of an antimicrobial agent containing one or more lectins contained in an amount of approximately 0.01 % to 1 % in terms of the total weight of said composition; and one or more additional antimicrobial agents selected from a group consisting of a physiologically acceptable water-soluble metal salt, carrageenan and combinations thereof; and an acetate buffer. To inhibit one or more microbial infections, an effective amount of said composition is administered into a subject. Also provided is a method of inhibiting HPV infection in a subject, which involves administering an effective amount of said composition.
EFFECT: using the group of inventions enables higher effectiveness of inhibiting one or more microbial infections in a subject.
23 cl, 3 dwg, 2 tbl, 6 ex
Title | Year | Author | Number |
---|---|---|---|
CARAGEENAN-CONTAINING AQUEOUS ANTIMICROBIAL COMPOSITIONS | 2010 |
|
RU2540423C2 |
ANTIVIRAL AGENT AGAINST HERPES SIMPLEX VIRUS TYPE 1 | 2022 |
|
RU2782935C1 |
COMPOSITIONS AND METHODS FOR SIMULTANEOUS DETECTION OF HCV ANTIGEN/ANTIBODY | 2014 |
|
RU2667429C2 |
AGENT FOR EXTERNAL USE WITH ANTIVIRAL ACTION | 2021 |
|
RU2819719C2 |
COMPOSITIONS AND METHODS FOR TREATING CYTOMEGALOVIRUS | 2012 |
|
RU2737530C1 |
INHIBITION OF BIOFILM ORGANISMS | 2010 |
|
RU2548786C2 |
COMPOSITIONS AND METHODS FOR INHIBITING INFLAMMATION AND DISEASES USING ALGINIC ACID-BASED ANTIMICROBIAL COMPOUND | 2014 |
|
RU2691950C1 |
GLYCAN-DEPENDENT IMMUNOTHERAPY MOLECULES | 2016 |
|
RU2754661C2 |
PHARMACEUTICAL SALTS OF 3-O-(3',3-DIMETHYLSUCCINYL) BETULINIC ACID | 2005 |
|
RU2387665C2 |
COMPOSITIONS AND METHODS FOR APPLYING PHORBOL ESTERS | 2008 |
|
RU2472511C2 |
Authors
Dates
2019-08-09—Published
2015-01-13—Filed